Separator

Guttify Unveils India's First Clinically-Backed At-Home Kit for Fatty Liver Management

Tuesday, 10 June 2025, 11:31 IST
Separator
  • Guttify introduces Liver Lift, India’s first at-home, clinically-backed fatty liver management kit with natural supplements and expert guidance.
  • The kit supports liver detox, reduces bloating, and promotes wellness designed for health-conscious, time-constrained users.
  • Priced at Rs 999, it’s available on major e-commerce platforms; launch follows Guttify’s USD 360K seed fund raise in May 2025.

Guttify, a premium gut health brand recognised for its diagnosis-first approach, has unveiled Liver Lift, India’s first clinically-guided, at-home kit designed for managing fatty liver disease. This innovative solution addresses the rising need for preventive, lifestyle-based healthcare, particularly among health-conscious individuals leading busy lives.

The Liver Lift Kit combines natural, plant-based supplements featuring ingredients like milk thistle, dandelion, and moringa with expert-led dietary guidance and personalised lifestyle recommendations. Backed by clinical research, the kit is designed to support liver detoxification, reduce bloating, and promote overall wellness all from the comfort of home.

Commenting on the launch, Mukul Shah, Founder of Guttify, said, “The Liver Lift Kit is our answer to a growing yet overlooked health crisis in India. Fatty liver silently affects millions, including those who appear healthy, but rarely gets the attention it needs. As India transitions toward preventive healthcare, this science-backed solution empowers users to naturally and affordably improve their liver and gut health with minimal disruption to their daily lives”.

Also Read: Ayushman Bharat Drives Historic Health Progress in 11 Years: JP Nadda

Priced at Rs 999, the Liver Lift Kit is now available on Guttify’s official website, Amazon India, and Flipkart. The company also plans to expand to quick-commerce platforms soon.

The launch comes on the heels of Guttify securing USD 360,000 in extended seed funding in May 2025, bringing its total funding to over USD 1 million. The company plans to use the capital to expand its range of diagnosis-first, at-home gut wellness products across both urban and semi-urban markets in India.